Peder Frederiksen
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Fibroblast activity biomarkers are associated with mortality in severe COVID-19: a post-hoc analysis of a phase 2 clinical trial.
Journal: Respiratory research
Published: March 25, 2026
Therapeutic subtypes of knee osteoarthritis: differential treatment effects among predicted endotypes in past clinical trials.
Journal: Arthritis research & therapy
Published: December 29, 2025
Weight loss ameliorates symptoms of osteoarthritis and is correlated with alterations in soluble bone and cartilage markers: an analysis of patient-reported outcomes and biomarkers.
Journal: BMC rheumatology
Published: August 25, 2025
The role of type I collagen fragment C1M in knee osteoarthritis. A longitudinal biomarker study using data from the OA-FNIH consortium.
Journal: Osteoarthritis and cartilage
Published: August 08, 2025
Axial spondyloarthritis, psoriatic arthritis and systemic lupus erythematosus share common molecular features based on post-hoc analysis of serum biomarkers.
Journal: Rheumatology international
Published: June 11, 2025
Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib.
Journal: Scientific reports
Published: August 15, 2024
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohorts.
Journal: Thorax
Published: May 01, 2024
Longitudinal stability of molecular endotypes of knee osteoarthritis patients.
Journal: Osteoarthritis and cartilage
Published: April 30, 2024
Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis.
Journal: Diabetes, obesity & metabolism
Published: April 18, 2024
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: April 18, 2024
Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab.
Journal: Arthritis research & therapy
Published: September 29, 2023
Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.
Journal: RMD open
Published: September 28, 2023
Last Updated: 09/26/2026